Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment

BACKGROUND: Levodopa is regarded as a standard medication in Parkinson disease (PD) treatment. However, long-term administration of levodopa leads to levodopa-induced dyskinesia (LID), which can markedly affect patient quality of life. Previous studies have shown that neuroinflammation in the brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Xiao-Xiao, Wang, Jin, Cai, Hua-Ying, Jiang, Hong, Jiang, Jin-Zhan, Chen, Hao-Hao, Han, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273834/
https://www.ncbi.nlm.nih.gov/pubmed/35836722
http://dx.doi.org/10.2147/JIR.S368291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273834/
https://www.ncbi.nlm.nih.gov/pubmed/35836722
http://dx.doi.org/10.2147/JIR.S368291

Ejemplares similares